This $2,490,060 Cooperative Agreement award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) supports research to optimize public health communication strategies on the continuum of risk for tobacco products. The project aims to assess the effects of FDA tobacco product risk continuum messaging on adult combustible tobacco users and youth/young adult tobacco users or...
This Project Grant award of $622,957 from the National Institutes of Health (NIH) Office of the Director, under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), supports research by Duke University to investigate the chemical composition and behavioral effects of novel tobacco products, including oral nicotine pouches and "non-menthol" cigarettes. The study aims to analyze the flavors, sweeteners, and nicotine forms in these products, and...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) totaling $885,824 aims to assess consumer response to smokeless tobacco modified risk marketing orders. The research activities will explore 1) consumers' exposure and reactions to authorized smokeless tobacco modified risk tobacco product (MRTP) claims, and 2) whether the MRTP claims influence smokeless tobacco demand and sensory evaluations. The project will be conducted...
This $2,353,743 Project Grant awarded by the National Institutes of Health (NIH) under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) will support research on the prevalence and effects of "natural" descriptors used in cigar packaging. The project aims to: 1) analyze Nielsen cigar sales data and purchased cigar packs to examine the use of "natural" themed descriptors and imagery on cigar packaging over time, 2) test the effects...
The federal Project Grant award R21CA292195 was provided by the National Cancer Institute (NCI), which administers the Cancer Cause and Prevention Research (CFDA 93.393) program. The $226,504 award will fund a 2-year study to examine tobacco use behaviors and related mechanisms among U.S. adults and youth representing minority and intersecting minority identities, such as racial/ethnic minorities, sexual/gender minorities, low socioeconomic status, and rural populations. The research aims to...
The National Institutes of Health (NIH) Office of the Director awarded a $1,197,896 Project Grant under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) to the University of Oklahoma Health Sciences Center. The objective of this 5-year longitudinal study is to use traditional survey methods combined with ecological momentary assessment (EMA) to better understand the impact of electronic nicotine delivery system (ENDS) product characteristics on...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will provide $431,750 to Rutgers, The State University of New Jersey to conduct a multi-method investigation of premium cigar use and marketing. The key objectives are to: 1) understand consumer experiences and perceptions of premium cigars through focus groups; 2) document and characterize premium cigar marketing through a longitudinal content...
This Project Grant award of $371,822.00 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) aims to advance the science on the impact of cigar package quantity on cigar use behaviors. The project, awarded to Rutgers, The State University of New Jersey, has two main objectives: 1) characterize changes in cigar pack size over time and assess its impact on sales, consumption, and patterns of use using secondary data sources, and 2) examine...
This Project Grant award of $515,632 from the National Cancer Institute's (NCI) Cancer Cause and Prevention Research program (CFDA 93.393) supports research to prepare the U.S. and state governments for the potential implementation of two cigarette product standards by the FDA - a menthol ban and a nicotine reduction standard. The key objectives are to: 1) Estimate for each U.S. state the increase in people who smoke that would quit and enroll in quit lines following the implementation of...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA Program 93.077 - Family Smoking Prevention and Tobacco Control Act Regulatory Research provides $188,913 to Virginia Commonwealth University (VCU) from August 1, 2024 to July 31, 2029. The purpose of the grant is to assess perceptions of the continuum of risk among socioeconomically disadvantaged adult smokers, design and test educational messages about the relative risks of...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA 93.310 (Trans-NIH Research Support) is supporting a $675,599 study titled "Implementation, Reach, and Impact of Court-Ordered Tobacco Corrective Statement Postings at the Point-of-Sale". The primary awardee is Rutgers, The State University of New Jersey, who will collaborate with Columbia University on the project. The study aims to: 1) characterize the implementation and reach of court-ordered tobacco corrective statements displayed at over 200,000 retail locations nationwide; 2) use eye-tracking to explore consumer attention to the corrective statements; and 3) conduct longitudinal surveys to assess the impact on tobacco knowledge, attitudes, intentions, and behaviors among adults and youth. This time-sensitive research opportunity seeks to generate insights that can inform future large-scale tobacco education efforts and identify populations that may need supplemental health programs.